Literature DB >> 1653248

Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment.

I Pongratz1, P E Strömstedt, G G Mason, L Poellinger.   

Abstract

The dioxin receptor stimulates transcription of the cytochrome P-450IA1 gene in response to dioxin. Exposure of the intracellular dioxin receptor to dioxin leads to a rapid conversion of the receptor from a latent form to a DNA binding species which specifically recognizes dioxin-responsive positive control elements in vitro. In this report, we show that treatment of in vivo or in vitro ligand-activated receptor with potato acid phosphatase significantly reduced or abolished its specific DNA binding activity. This effect was inhibited in the presence of sodium phosphate. In control experiments, the ligand-activated glucocorticoid receptor was not inactivated by phosphatase treatment. Moreover, phosphatase treatment did not induce any detectable degradation of covalently labeled dioxin receptor, arguing against protease contamination as a cause for receptor inactivation. Finally, phosphatase-inactivated dioxin receptor exhibited bona fide levels of ligand binding activity. Taken together, these data suggest that phosphorylation may regulate the DNA binding activity of the ligand-occupied dioxin receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653248

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Ligand-dependent recruitment of the Arnt coregulator determines DNA recognition by the dioxin receptor.

Authors:  M Whitelaw; I Pongratz; A Wilhelmsson; J A Gustafsson; L Poellinger
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

2.  Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism.

Authors:  A Berghard; K Gradin; I Pongratz; M Whitelaw; L Poellinger
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

3.  Ah Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-Motifs.

Authors:  D P Jackson; A D Joshi; C J Elferink
Journal:  Toxicol Res (Camb)       Date:  2015-03-17       Impact factor: 3.524

4.  Activation of the aryl hydrocarbon receptor AhR Promotes retinoic acid-induced differentiation of myeloblastic leukemia cells by restricting expression of the stem cell transcription factor Oct4.

Authors:  Rodica P Bunaciu; Andrew Yen
Journal:  Cancer Res       Date:  2011-01-24       Impact factor: 12.701

5.  Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor.

Authors:  P J Kallio; I Pongratz; K Gradin; J McGuire; L Poellinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

Review 6.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.

Authors:  Alvaro Puga; Ci Ma; Jennifer L Marlowe
Journal:  Biochem Pharmacol       Date:  2008-09-05       Impact factor: 5.858

7.  Sulfonation and phosphorylation of regions of the dioxin receptor susceptible to methionine modifications.

Authors:  Keyur A Dave; Fiona Whelan; Colleen Bindloss; Sebastian G B Furness; Anne Chapman-Smith; Murray L Whitelaw; Jeffrey J Gorman
Journal:  Mol Cell Proteomics       Date:  2008-12-04       Impact factor: 5.911

8.  Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.

Authors:  K M Burbach; A Poland; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

9.  Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation.

Authors:  F Carrier; R A Owens; D W Nebert; A Puga
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

10.  Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer.

Authors:  Dan J M Nguyen; George Theodoropoulos; Ying-Ying Li; Chunjing Wu; Wei Sha; Lynn G Feun; Theodore J Lampidis; Niramol Savaraj; Medhi Wangpaichitr
Journal:  Mol Cancer Res       Date:  2019-10-18       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.